Providing stock analysis for investors of the Canadian junior markets
PharmaDrug (CSE: PHRX) this morning revealed the strategic plans for its Sairiyo Therapeutics subsidiary in relation to the clinical development of PD-001, its patented formulation for an enteric-coated version of cepharanthine.
Read more
Switzerland is currently reevaluating its stance on drug policy as reports emerge of a groundbreaking proposal to legalize the sale of cocaine for recreational use in the capital city of Bern. This comes in response to mounting evidence suggesting that the country’s longstanding “war on drugs” has proven ineffective.
Read more